Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
33.56
+0.09 (0.27%)
Aug 14, 2026, 4:00 PM EDT - Market closed

Agios Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
99.6589.1376.2588.21139.26203.13
Short-Term Investments
517.93765.3817.46688.72643.86816.89
Cash & Short-Term Investments
617.58854.43893.71776.93783.121,020
Cash Growth
-34.23%-4.40%15.03%-0.79%-23.23%78.04%
Accounts Receivable
24.2210.584.112.812.21-
Other Receivables
-0.2-1.10.37.28
Receivables
24.2210.784.113.912.517.28
Inventory
30.1532.9227.6219.088.49-
Prepaid Expenses
45.7243.9340.1733.9238.6636.94
Total Current Assets
717.67942.05965.6833.84832.771,064
Property, Plant & Equipment
33.8241.2354.5569.7988.12104.23
Long-Term Investments
347.25310.01638.3229.44313.87266.38
Other Long-Term Assets
9.683.934.724.063.962.9
Total Assets
1,1081,2971,663937.121,2391,438

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
16.3518.3616.649.7818.6216.7
Accrued Expenses
34.6545.4646.8643.1730.3531.97
Current Portion of Leases
19.2318.3916.7815.0113.6611.16
Current Income Taxes Payable
--0.87---
Total Current Liabilities
70.2282.2181.1667.9662.6359.83
Long-Term Leases
11.9521.8240.2156.997285.94
Other Long-Term Liabilities
0.240.090.881.163.28-
Total Liabilities
82.4104.11122.24126.1137.9145.76

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.080.080.070.070.070.07
Additional Paid-In Capital
2,5922,5552,4942,4372,3862,334
Retained Earnings
-761.52-561.71-148.92-822.65-470.56-238.76
Treasury Stock
-802.49-802.49-802.49-802.49-802.49-802.49
Comprehensive Income & Other
-1.82.19-1.52-0.44-12.54-1.2
Shareholders' Equity
1,0261,1931,541811.021,1011,292
Total Liabilities & Equity
1,1081,2971,663937.121,2391,438

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
31.1740.2156.997285.6697.09
Net Cash (Debt)
933.661,1241,475734.371,0111,189
Net Cash Growth
-27.66%-23.78%100.86%-27.39%-14.96%110.37%
Net Cash Per Share
15.9119.3925.4813.2018.4619.67
Filing Date Shares Outstanding
59.758.5957.356.1955.2954.64
Total Common Shares Outstanding
59.658.4557.1655.9555.0454.33
Working Capital
647.45859.85884.44765.88770.141,004
Book Value Per Share
17.2120.4126.9614.5020.0023.78
Tangible Book Value
1,0261,1931,541811.021,1011,292
Tangible Book Value Per Share
17.2120.4126.9614.5020.0023.78
Machinery
-30.6229.7629.7335.1233.8
Construction In Progress
-2.750.90.610.667.37
Leasehold Improvements
-37.5237.5237.2837.2832.73
SEC Filings: 10-K · 10-Q